ACCESSION: MSBNK-SMB_Measured-HSA015P0125009
RECORD_TITLE: Characterized; 1-butylimidazole; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL01_pos_3033': {'bp': 301201.0, 'sum': 982744.0}, 'EL02_pos_3045': {'bp': 296465.0, 'sum': 1126958.0}, 'EL05_pos_3041': {'bp': 253931.0, 'sum': 853143.0}, 'EL11_pos_3027': {'bp': 237091.0, 'sum': 768932.0}, 'EL06_pos_3033': {'bp': 223448.0, 'sum': 716906.0}, 'EL07_pos_3027': {'bp': 222788.0, 'sum': 732801.0}, 'EL04_pos_3039': {'bp': 219563.0, 'sum': 804708.0}, 'EL09_pos_3028': {'bp': 203428.0, 'sum': 685048.0}, 'EL24_pos_3055': {'bp': 203007.0, 'sum': 686262.0}, 'EL08_pos_3034': {'bp': 193251.0, 'sum': 795481.0}, 'EL23_pos_3046': {'bp': 192556.0, 'sum': 836799.0}, 'EL10_pos_3033': {'bp': 188077.0, 'sum': 661007.0}, 'EL13_pos_3039': {'bp': 164044.0, 'sum': 645755.0}, 'EL16_pos_3039': {'bp': 116886.0, 'sum': 547101.0}}
COMMENT: RETENTION_TIME_STDEV 0.011
COMMENT: PRECURSOR_M/Z_RAW 125.107628
COMMENT: PRECURSOR_M/Z_STDEV 0.000048
COMMENT: PRECURSOR_IN_MS1 mz 125.107331; int 79.222; delta(ppm) 0.732419
COMMENT: PROPOSED_CHARGE_STATE +1; mz 126.110709; int 5.603; cor 0.705
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.032; C7H12N2; [M+H]+; delta(ppm) 0.032232
COMMENT: PROPOSED_MF MS-FINDER 3.538; C7H12N2; [M+H]+; delta(ppm) 0.025342
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.161; C7H12N2; [M+H]+; delta(ppm) 0.025342
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N2; [M+H]+; delta(ppm) 0.025342
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.451; C7H12N2; [M+H]+; delta(ppm) 0.025342
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N2; [M+H]+; delta(ppm) 0.025342
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.904; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; CCCCC1=NC=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.668; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; CCN1CN(C=C1)C=C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.812; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.534; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.793; MCMFEZDRQOJKMN-UHFFFAOYSA-N; [M+H]+; 1-butylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.724; SGUVLZREKBPKCE-UHFFFAOYSA-N; [M+H]+; 2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.093; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.744; HUMMCZRNZCKXHL-UHFFFAOYSA-N; [M+H]+; 1-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.460; PDVYZQGNSCSKPG-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.459; CLVBVRODHJFTGF-UHFFFAOYSA-N; [M+H]+; 2-piperidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.346; YIDCITOHTLPMMZ-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.315; GFJCGXFXOXSUJX-UHFFFAOYSA-N; [M+H]+; 5-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.314; NKYDATLMFPYEJM-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropyl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; AMQKPABOPFXDQM-UHFFFAOYSA-N; [M+H]+; 1-tert-butylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; QOLDCHQHOOFRGQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.178; SWEZGJVIOFBJBX-UHFFFAOYSA-N; [M+H]+; 5-methyl-4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.178; BVGQGPWKBMTPNM-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.175; GDRRCHJTUJBMQA-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.154; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.134; IGSGRZGYPSFKAS-UHFFFAOYSA-N; [M+H]+; 4-butan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; CTUNHIMNHSKDBN-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; OZLQTEIBZXQTLQ-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-2-(methylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; IEGLIUHTOPMAFW-UHFFFAOYSA-N; [M+H]+; 1-(2-isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; KLKXWOZRCZWLNA-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; QUSOBKIKODRYSH-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; KNIPASVZFLFVSD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; RVGOKHBYNZPVGI-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; IYTBULKZSACADZ-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; WOPVVVYENHYREL-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopentylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; JYOKDJPITDWCEZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; IJRFANCSEQXUNT-UHFFFAOYSA-N; [M+H]+; 2-(methylamino)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.974; KMUHAJOXPNPERW-UHFFFAOYSA-N; [M+H]+; (1,5-dimethylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.959; UFLLSVUGUWBXJA-UHFFFAOYSA-N; [M+H]+; 3,5-diethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; MGSZBMLUKBKFIH-UHFFFAOYSA-N; [M+H]+; 4-ethyl-3,5-dimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; WLUJHMKCLOIRSK-UHFFFAOYSA-N; [M+H]+; 1,2,4,5-tetramethylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; GWCSATTUAOHJDK-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; GUFHZYGWUDAKJR-UHFFFAOYSA-N; [M+H]+; (5-ethyl-1H-pyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; HZJOVDAZLMBPPZ-UHFFFAOYSA-N; [M+H]+; 2-piperidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; ITFDYXKCBZEBDG-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; KJENYXWFEZWBBS-UHFFFAOYSA-N; [M+H]+; (2,5-dimethyl-1H-pyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; BJIDGKXFJLYGNA-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(1H-pyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; UGOZVQRJDQYTKT-UHFFFAOYSA-N; [M+H]+; N-methyl-2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; SFRZJVGGJFNWHZ-UHFFFAOYSA-N; [M+H]+; 4-tert-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.782; ULKZTFQDSPKNMV-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.724; VIXYONLJAGTTOD-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.697; XMTHAWZPEGHZPK-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.599; LOCUKVKZMLTDJC-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.448; ZVTFIBQPABQXLK-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.389; ITGMTNOYOPHQAE-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.387; MXDKDPXBTLQXNF-RNFRBKRXSA-N; [M+H]+; 2-[(1S,3R)-3-aminocyclopentyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.336; CNRYJJXBFLHSJP-UHFFFAOYSA-N; [M+H]+; 3-pyrrol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -14.856; MCMFEZDRQOJKMN; [M+H]+; N-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -77.880; SLLDUURXGMDOCY; [M+H]+; 2-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.606; RFXJLECGYGFJCI; [M+H]+; Ambcb4039941
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.153; CTUNHIMNHSKDBN; [M+H]+; Ambcb4039818
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.912; WLUJHMKCLOIRSK; [M+H]+; 1,2,4,5-Tetramethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.087; CNRYJJXBFLHSJP; [M+H]+; Ambcb4027319
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.722; PDVYZQGNSCSKPG; [M+H]+; 1-Pyrrolidinepropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.175; IEGLIUHTOPMAFW; [M+H]+; 1-(2-isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.237; KVMUMGRJMXZCMW; [M+H]+; 2-Ethyl-5,6-dihydro-3-methylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.634; SGUVLZREKBPKCE; [M+H]+; 1,5-Diazabicyclo[4.3.0]-5-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.427; ITFDYXKCBZEBDG; [M+H]+; 1-Methyl-1H-pyrrole-2-ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.401; CLVBVRODHJFTGF; [M+H]+; Piperidoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.072; ZVTFIBQPABQXLK; [M+H]+; piperidinylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.816; GFJCGXFXOXSUJX; [M+H]+; 3-Butylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.655; KMUHAJOXPNPERW; [M+H]+; (1,5-dimethylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.122; GWCSATTUAOHJDK; [M+H]+; Ambcb4040562
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.380; XMTHAWZPEGHZPK; [M+H]+; 1-(1H-pyrrol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.777; YVYGFQPWNRTJNS; [M+H]+; 2,3,5-Trimethyl-5,6-dihydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.844; HQOXLKBFOCPYAE; [M+H]+; 5,7-dimethyl-2,3-dihydro-1H-1,4-diazepine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.576; OKDQKPLMQBXTNH; [M+H]+; Pyridinamine,N,N-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.495; HUMMCZRNZCKXHL; [M+H]+; Ambcb4036030
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -286.568; YIDCITOHTLPMMZ; [M+H]+; Bionet2_000181
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.807; MCMFEZDRQOJKMN; [M+H]+; N-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -23.035; MCMFEZDRQOJKMN; [M+H]+; 1-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.719; RFXJLECGYGFJCI; [M+H]+; 2-(2-Methylpropyl)-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -48.991; AMQKPABOPFXDQM; [M+H]+; 1-t-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.678; SLLDUURXGMDOCY; [M+H]+; 2-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -76.465; CTUNHIMNHSKDBN; [M+H]+; 2-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.206; BVGQGPWKBMTPNM; [M+H]+; 4-Methyl-2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.390; WLUJHMKCLOIRSK; [M+H]+; 2-(Deuteriomethyl)-1,4,5-trimethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -110.700; ULKZTFQDSPKNMV; [M+H]+; 4-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.008; UVQPDGXQIPNYNU; [M+H]+; 3-Ethenyl-1-ethyl-1,2-dihydroimidazol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.398; YVYGFQPWNRTJNS; [M+H]+; 2,3-Dihydro-2,5,6-trimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.758; MCMFEZDRQOJKMN; [M+H]+; 1-Butylimidazole
COMMENT: CONFIDENCE Level 3: Tentative candidate, 1-Butylimidazole, MCMFEZDRQOJKMN-UHFFFAOYSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1);
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C7H12N2
CH$EXACT_MASS: 124.100048
CH$SMILES: CCCCN1C=CN=C1
CH$IUPAC: InChI=1S/C7H12N2/c1-2-3-5-9-6-4-8-7-9/h4,6-7H,2-3,5H2,1H3
CH$NAME: Butylimidazole
CH$NAME: 1-butylimidazole
CH$LINK: INCHIKEY MCMFEZDRQOJKMN-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:61347
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.911
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 125.107328
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00b9-3900000000-6b6bf07412f62a8c3d29
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.9650076 18.9126 56.965724 1.2464 8.97 -0.0681 14 ?
  57.0701004 22.4000 57.070817 1.0513 3.45 0.7912 13 f{C4H9}/3.92ppm,p-C3H4N2
  58.0653067 11.9590 58.066027 1.3261 4.83 0.2364 10 f{C3H8N1}/3.12ppm,p-C4H5N1
  67.0542902 18.0877 67.055032 0.8650 6.16 0.3566 12 f{C5H7}/0.95ppm,p-C2H6N2
  67.9349877 14.8163 67.935730 1.5309 6.41 -0.3697 10 ?
  69.0448906 140.4876 69.045634 0.3910 12.93 0.7495 14 f{C3H5N2}/2.40ppm,p-C4H8
  79.0543055 41.4563 79.055038 0.7463 11.78 0.0824 13 f{C6H7}/1.00ppm,p-C1H6N2
  80.0494967 42.6250 80.050226 1.2742 14.95 0.1593 13 f{C5H6N1}/0.26ppm,p-C2H7N1
  81.0447877 12.7087 81.045514 0.9131 3.61 0.2867 12 f{C4H5N2}/0.78ppm,p-C3H8
  81.0572786 11.7607 81.058005 1.0363 2.56 0.4667 10 f{C5H7N1}/-0.27ppm,p-C2H6N1
  81.0699450 51.9301 81.070671 0.7648 13.91 0.3846 14 f{C6H9}/0.84ppm,p-C1H4N2
  82.0526026 152.8872 82.053326 0.4631 8.47 0.9516 14 f{C4H6N2}/0.65ppm,p-C3H7
  82.0652119 12.6279 82.065935 1.4257 2.97 0.5273 10 f{C5H8N1}/1.05ppm,p-C2H5N1
  82.9419570 16.6402 82.942677 1.5915 6.69 -0.0714 13 ?
  83.0604635 12.9021 83.061183 1.3845 3.26 0.5515 10 f{C4H7N2}/1.07ppm,p-C3H6
  84.9597511 286.4256 84.960463 0.3649 82.20 -0.3143 14 ?
  95.0603397 11.6498 95.060992 1.4307 2.75 0.5879 13 f{C5H7N2}/-0.37ppm,p-C2H6
  96.0444534 46.9007 96.045099 1.3223 11.17 0.2879 14 ?
  106.0651328 14.5870 106.065686 1.6216 4.97 0.1484 13 f{C7H8N1}/0.07ppm,p-H5N1
  107.0729968 363.4829 107.073539 0.4856 86.34 0.4462 14 f{C7H9N1}/0.43ppm,p-H4N1
  118.9629990 14.9775 118.963448 1.5131 3.84 0.1758 10 ?
  123.0552861 50.4121 123.055696 1.2515 16.69 0.0559 12 ?
  123.0803076 13.2882 123.080717 1.8849 5.87 -0.1515 10 ?
  124.0394560 91.3183 124.039856 0.9674 28.17 0.0505 14 ?
  124.0757271 625.9506 124.076126 0.3224 163.82 0.4418 14 ?
  125.0709681 24.4299 125.071357 1.4472 7.40 0.0989 14 ?
  125.0792197 42.9500 125.079609 0.5676 14.63 0.3846 14 ?
  125.1073621 999.0000 125.107751 0.3757 21.36 1.0000 14 f{C7H13N2}/0.30ppm,p
  126.0548123 19.3532 126.055191 1.4438 7.11 -0.0091 11 ?
  126.0913472 37.3194 126.091725 1.2927 21.53 0.1703 13 ?
  126.1109234 85.3464 126.111301 0.9833 8.93 0.8242 14 ?
  127.0390520 22.8126 127.039420 1.8341 6.20 0.1000 11 ?
PK$NUM_PEAK: 32
PK$PEAK: m/z int. rel.int.
  56.965008 18.91 18
  57.070100 22.40 22
  58.065307 11.96 11
  67.054290 18.09 18
  67.934988 14.82 14
  69.044891 140.49 140
  79.054306 41.46 41
  80.049497 42.62 42
  81.044788 12.71 12
  81.057279 11.76 11
  81.069945 51.93 51
  82.052603 152.89 152
  82.065212 12.63 12
  82.941957 16.64 16
  83.060464 12.90 12
  84.959751 286.43 286
  95.060340 11.65 11
  96.044453 46.90 46
  106.065133 14.59 14
  107.072997 363.48 363
  118.962999 14.98 14
  123.055286 50.41 50
  123.080308 13.29 13
  124.039456 91.32 91
  124.075727 625.95 625
  125.070968 24.43 24
  125.079220 42.95 42
  125.107362 999.00 999
  126.054812 19.35 19
  126.091347 37.32 37
  126.110923 85.35 85
  127.039052 22.81 22
//
